About Dial Pharmaceuticals Private Limited
Data last updated:
Dial Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 September 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ2003PTC042823. Its GSTIN is 24AABCD9072H1ZO (Gujarat).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Rannaben Sanjaybhai Sheth and Bindiben Jayeshbhai Sheth.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3701 / A Phase Ivg I D C Estate Vatva, Ahmedabad, Gujarat, India – 382445.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.84 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net loss of ₹1.21 Cr (net margin -31.6%) and EBITDA of -₹1.32 Cr (EBITDA margin -34.3%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 7% over five years.
The company has about 19 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.75 Cr and satisfied charges of ₹16.06 Cr on record. Court records list 4 cases involving the company, including 2 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dialpharmaceuticals.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address3701 / A Phase Ivg I D C Estate Vatva, Ahmedabad, Gujarat, India – 382445
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dial Pharmaceuticals Private Limited
The main business activity of Dial Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dial Pharmaceuticals Private Limited FY 2025 filings available
Dial Pharmaceuticals Private Limited reported revenue of ₹3.84 Cr (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Dial Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 3% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dial Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.32 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.21 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dial Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -34.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -31.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dial Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Dial Pharmaceuticals Private Limited
Dial Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Olwen Lifesciences Private Limited | •••• | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
| Phorcys Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Ernakulam, Kerala, India |
| Udayam Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Chennai, Tamil Nadu, India |
| Neova Biogene Private Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Samai Healthcare Private Limited | •••• | •••• | •••• | •••• | 11 | Mumbai, Maharashtra, India |
| Dial Pharmaceuticals Private Limited this company | •••• | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
| Alive Lifescience Private Limited | •••• | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
| Dharuhera Pharmaceuticals Pvt Ltd | •••• | •••• | •••• | •••• | 26 | New Delhi, Delhi, India |
| Alentica Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Ambrosia Chemicals & Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Nagpur, Maharashtra, India |
| Burgeon Health Series Private Limited | •••• | •••• | •••• | •••• | - | Chandigarh, India |
Peers are the five companies nearest above and the five nearest below Dial Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Dial Pharmaceuticals Private Limited
Dial Pharmaceuticals Private Limited is audited by Pankaj K. Shah & Co. for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Pankaj K. Shah & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Dial Pharmaceuticals Private Limited
Dial Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sharadchandra Rasiklal Shah | Additional Director | 07 Aug 2025 | 1 Years 2 Months | Current |
| Darshan Sharadchandra Shah Also directs: Swiss Sterile Private Limited, Swiss Pharma Pvt Ltd, Sapphire Medicare Private Limited and 2 more | Additional Director | 07 Aug 2025 | 1 Years 2 Months | Current |
| Rannaben Sanjaybhai Sheth | Director | 01 Sep 2003 | 23 Years 1 Months | Current |
| Bindiben Jayeshbhai Sheth | Director | 01 Sep 2003 | 23 Years 1 Months | Current |
Ownership and Shareholding of Dial Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dial Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Sep 2025 | Others | ₹4.75 Cr | Open |
| 27 Nov 2020 | Others | ₹2.9 Cr | Satisfied |
| 16 Jun 2020 | Sidbi | ₹50 Lakh | Satisfied |
| 17 Dec 2019 | Others | ₹7.48 Cr | Satisfied |
| 17 Jun 2017 | Others | ₹2.38 Cr | Satisfied |
Total charge records: 8 View all charges
Legal Cases of Dial Pharmaceuticals Private Limited
Dial Pharmaceuticals Private Limited has 4 court cases on record: 2 filed against it, 2 where it is another party. 2 cases are pending and 2 are disposed. Status as checked between 01 Oct 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 2 | 2 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Sangli, Maharashtra | Civil suit | Company is another party | Pending |
| District court, New Delhi, Delhi | Court case (CS (COMM.)) | Company is another party | Pending |
| District court, Ahmedabad, Gujarat | Court case (REFER-T-LC) | Filed against the company by an individual | Disposed |
| District court, Ahmedabad, Gujarat | Court case (RECO33C2-LC) | Filed against the company by an individual | Disposed |
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Dial Pharmaceuticals Private Limited
Dial Pharmaceuticals Private Limited has 3 MSME Form 1 returns on record between 2019 and 2021, listing 34 overdue payments to 10 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 10)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Dhruvi Offset | •••• | •••• | •••• |
| Meghna Granules | •••• | •••• | •••• |
| Dhruvi Offset | •••• | •••• | •••• |
| Aum Research Laboratories | •••• | •••• | •••• |
| Pacemaker Pharma Chem | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 3 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Dial Pharmaceuticals Private Limited
Dial Pharmaceuticals Private Limited has a workforce of 19 employees as of Mar 24, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dial Pharmaceuticals Private Limited
Dial Pharmaceuticals Private Limited has 7 board changes on record since 2003: 4 appointments and 3 cessations. The latest: Darshan Sharadchandra Shah was appointed as Additional Director on 07 Aug 2025.
17 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Dial Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dial Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dial Pharmaceuticals Private Limited
Dial Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AABCD9072H1ZO | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dial Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dial Pharmaceuticals Private Limited
Dial Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 September 2003 (23+ years old) and is registered under CIN U24231GJ2003PTC042823.
Dial Pharmaceuticals reported revenue of ₹3.84 Cr for FY 2025 (down 3% YoY).
Dial Pharmaceuticals has 4 current directors:
- Sharadchandra Rasiklal Shah - Additional Director
- Darshan Sharadchandra Shah - Additional Director
- Rannaben Sanjaybhai Sheth - Director
- Bindiben Jayeshbhai Sheth - Director
Dial Pharmaceuticals reported a net loss of ₹1.21 Cr (net margin -31.6%) and EBITDA of -₹1.32 Cr (EBITDA margin -34.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dial Pharmaceuticals is -7% over three years and -7% over five years. In the latest year (FY 2025) revenue fell 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Dial Pharmaceuticals is 24AABCD9072H1ZO, registered in Gujarat.
The CIN (Corporate Identification Number) of Dial Pharmaceuticals is U24231GJ2003PTC042823. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dial Pharmaceuticals has 4 court cases on record: 2 filed against it. 2 are pending.
Dial Pharmaceuticals was incorporated on 01 September 2003, making it 23+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Dial Pharmaceuticals by revenue are Olwen Lifesciences Private Limited, Phorcys Pharmaceuticals Private Limited, Udayam Pharmaceuticals Private Limited, Neova Biogene Private Limited, Samai Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Darshan Sharadchandra Shah was appointed as Additional Director on 07 Aug 2025. Sharadchandra Rasiklal Shah was appointed as Additional Director on 07 Aug 2025. Sanjay Jamnadas Sheth ceased to be Director on 09 Jun 2025. Dial Pharmaceuticals has 7 board changes on record in total.
Dial Pharmaceuticals has 3 MSME Form 1 returns on record between 2019 and 2021, listing 34 overdue payments to 10 micro and small suppliers. The latest return was filed on 13 May 2021.